We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$59.1B
AUM Growth
+$992M
Cap. Flow
-$2.48B
Cap. Flow %
-4.19%
Top 10 Hldgs %
13%
Holding
2,402
New
44
Increased
766
Reduced
639
Closed
78

Top Buys

Rank Stock Value
1
MSI icon
Motorola Solutions
MSI
+$537M
2
MTCH icon
Match Group
MTCH
+$93.8M
3
EW icon
Edwards Lifesciences
EW
+$90.7M
4
ROKU icon
Roku
ROKU
+$84.5M
5
BILL icon
BILL Holdings
BILL
+$78.9M

Sector Composition

Rank Sector Weight
1 Technology 18.03%
2 Healthcare 16.06%
3 Financials 13.24%
4 Industrials 10.22%
5 Consumer Discretionary 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVH icon
776
PVH
PVH
$3.87B
$5.71M 0.01%
95,797
-4,100
-4% -$226K
NOMD icon
777
Nomad Foods
NOMD
$1.67B
$5.71M 0.01%
224,200
-16,150
-7% -$383K
BAC.PRL icon
778
Bank of America Series L
BAC.PRL
$3.97B
$5.7M 0.01%
3,354
-1,268
-27% -$1.86M
AMAT icon
779
Applied Materials
AMAT
$410B
$5.69M 0.01%
95,748
+50,505
+112% +$3.12M
EFG icon
780
iShares MSCI EAFE Growth ETF
EFG
$16.4B
0
HLI icon
781
Houlihan Lokey
HLI
$9.75B
$5.68M 0.01%
96,272
+51,902
+117% +$2.97M
DOW icon
782
Dow Inc
DOW
$20.8B
$5.67M 0.01%
120,452
-13,879
-10% -$623K
ALLO icon
783
Allogene Therapeutics
ALLO
$604M
$5.61M 0.01%
148,783
CRSP icon
784
CRISPR Therapeutics
CRSP
$4.6B
$5.61M 0.01%
67,044
-28,296
-30% -$2.51M
HDB icon
785
HDFC Bank
HDB
$119B
$5.59M 0.01%
223,898
+13,688
+7% +$332K
KPTI icon
786
Karyopharm Therapeutics
KPTI
$161M
$5.57M 0.01%
25,422
AZN icon
787
AstraZeneca
AZN
$263B
$5.56M 0.01%
50,693
-717
-1% -$79.7K
CXO
788
DELISTED
CONCHO RESOURCES INC.
CXO
$5.54M 0.01%
125,613
+12,209
+11% +$609K
POLY
789
DELISTED
Plantronics, Inc.
POLY
$5.52M 0.01%
466,382
+40
+0% +$624
HPP
790
Hudson Pacific Properties
HPP
$794M
$5.5M 0.01%
35,820
-132
-0.4% -$21.7K
BWXT icon
791
BWX Technologies
BWXT
$16.2B
$5.49M 0.01%
97,511
+2,792
+3% +$157K
TEVA icon
792
Teva Pharmaceuticals
TEVA
$36.2B
$5.49M 0.01%
609,154
+49,726
+9% +$526K
NTNX icon
793
Nutanix
NTNX
$15.4B
$5.46M 0.01%
246,169
-10,010
-4% -$229K
TKR icon
794
Timken Company
TKR
$9.81B
$5.45M 0.01%
100,518
+58,992
+142% +$3.04M
ARES icon
795
Ares Management
ARES
$28.8B
$5.45M 0.01%
134,832
HUBB icon
796
Hubbell
HUBB
$26.3B
$5.45M 0.01%
39,815
-2,625
-6% -$361K
CNI icon
797
Canadian National Railway
CNI
$78B
$5.45M 0.01%
51,174
CBD
798
DELISTED
Companhia Brasileira de Distribuicao
CBD
$5.43M 0.01%
439,768
-7,129
-2% -$92.2K
DOX icon
799
Amdocs
DOX
$5.64B
$5.39M 0.01%
93,920
-100
-0.1% -$5.98K
ED icon
800
Consolidated Edison
ED
$41.1B
$5.34M 0.01%
68,637
+12,186
+22% +$899K

Similar funds

Macquarie Group's Q3 2020 Portfolio in Review

As of Q3 2020, Macquarie Group held 2,402 positions worth $59.1B, up 1.7% from $58.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group withdrew a net $2.48B in Q3 2020, closing 78 positions and reducing 639 holdings. Its most notable exit was Macquarie Infrastructure Holdings, LLC, an estimated $395M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Snowflake worth $6.37M.

  • Macquarie Group's largest Q3 2020 buy was Snowflake: 25,385 shares worth $6.37M.
  • Macquarie Group added most to Motorola Solutions in Q3 2020, an estimated $537M increase.
  • Macquarie Group's biggest Q3 2020 reduction was Abbott, cutting an estimated $659M.
  • Macquarie Group fully exited Macquarie Infrastructure Holdings, LLC in Q3 2020, selling an estimated $395M.
  • Macquarie Group's ten largest holdings make up 13% of its $59.1B portfolio in Q3 2020.
  • Macquarie Group opened 44 new positions and closed 78 in Q3 2020.
  • Macquarie Group's portfolio value rose 1.7% quarter-over-quarter to $59.1B.

Based on Macquarie Group's 13F filing for Q3 2020, filed 13 Nov 2020.